RE:Gilles, Ronnie, Bernhard and the 1$ sp"I cannot deny the fact that Ceapro has been a reserved company with negative marketing over the years. For example, company website and company presentation from Sept 2021."
CZO stated in its MD&A that is cut back on its IR spend last year. With a delivery technology with no delivery data, a fibrosis treatment without even a preclinical case completed, and an avenanthramide pill with no agreement to proceed to clinical trials or preclinical data released to date why not wait for actual data so that CZO knows what it actually has and an agreement to proceed to clinical trials so we know for sure what's next?
"The only measure that will determine CZO growth seems to be increased earnings. Would be great if Gilles, Ronnie and Bernhard would have some suprise news sometime soon."
It's not a bad thing to have a growing base business partnered with a C$20 billion company(Symrise) that is helping bring a pipeline forward to defning data.